WS #12989
Biogen reported better-than-expected Q2 results and raised FY26 adjusted EPS guidance above estimates.
Biogen Earnings Beat
Biogen reported better-than-expected Q2 results and raised FY26 adjusted EPS guidance above estimates.
Biogen reported better-than-expected Q2 results and raised FY26 adjusted EPS guidance above estimates.
Biogen reported better-than-expected Q2 results and raised FY26 adjusted EPS guidance above estimates.